Article

Efficacy of BTK inhibitor administered for central high-risk systemic diffuse large B cell lymphoma and primary central nervous system lymphoma: A single-center retrospective study

2024-01-03

Abstract excerpt

<title>Abstract</title> <p>Purpose This study was to explore the efficacy of Bruton's tyrosine kinase inhibitor (BTKi) in treating patients with central high-risk systemic diffuse large B cell lymphoma (DLBCL) and primary central nervous system lymphoma (PCNSL), while also assessing the influence of genomic variants on treatment outcomes. Materials and methods The safety, efficacy, and prognosis of patients tre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a6ee3e9b-5b78-5171-811e-c43a87b972b0
DOI: 10.21203/rs.3.rs-3782984/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Efficacy of BTK inhibitor administered for central high-risk systemic diffuse large B cell lymphoma and primary central nervous system lymphoma: A single-center retrospective studyDOI 10.21203/rs.3.rs-3782984/v1Read

Efficacy and safety of Orelabrutinib-based regimens in diffuse large B-cell lymphoma: A single-center retrospective analysisSemantic proximity Read

Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing.Semantic proximity Read

Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in TreatmentSemantic proximity Read

Whole-Genome/Exome Sequencing Uncovers Mutations and Copy Number Variations in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous SystemSemantic proximity Read

Genomic landscape and molecular subtypes of primary central nervous system lymphoma.Semantic proximity Read

Genomic Landscape and Molecular Subtypes of Primary Central Nervous System LymphomaSemantic proximity Read

Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses.Semantic proximity Read

Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphomaSemantic proximity Read

Mutational analysis of primary central nervous system lymphoma.Semantic proximity Read

Genomic characterization of primary central nervous system lymphoma.Semantic proximity Read

Primary Central Nervous System Lymphoma: Evolving Biologic Insights and Recent Therapeutic Advances.Semantic proximity Read

[Clinical Features and Prognosis of Patients with Primary Extranodal Diffuse Large B-Cell Lymphoma].Semantic proximity Read